Omeros (OMER) Total Debt (2010 - 2026)
Omeros (OMER) reported Total Debt of $52.8 million for Q1 2026, down 54.27% on a YoY basis from $115.5 million in Q1 2025, and down 22.82% sequentially from $68.4 million in Q4 2025.
Omeros (OMER) Total Debt (2010 - 2026) Analysis & Trends
Omeros (OMER) has 17 years of Total Debt data on file, last reported at $52.8 million in Q1 2026.
- For the quarter ending Q1 2026, Total Debt fell 54.27% year-over-year to $52.8 million; the trailing twelve-month figure through Mar 2026 stood at $52.8 million (down 54.27% YoY), and the FY2025 full-year result was $68.4 million, down 29.59% from the prior year.
- Total Debt slipped to $52.8 million in Q1 2026, from $68.4 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $316.7 million in Q3 2023 to a low of $52.8 million in Q1 2026.
- A 5-year average of $193.8 million and a median of $164.5 million in 2024 frame the typical range for Total Debt.
- Across the five-year window, Total Debt grew 0.61% in 2023 and plunged 70.82% in 2024, its largest moves.
- Tracing OMER's Total Debt over 5 years: stood at $315.3 million in 2022, then increased by 0.46% to $316.7 million in 2023, then plunged by 69.32% to $97.2 million in 2024, then retreated by 29.59% to $68.4 million in 2025, then retreated by 22.82% to $52.8 million in 2026.
- Business Quant data shows OMER's Total Debt at $52.8 million in Q1 2026, $68.4 million in Q4 2025, and $72.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 110.96 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 959.06 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | 52.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.81 Mn |
| Dec 31, 2025 | 68.43 Mn |
| Sep 30, 2025 | 72.08 Mn |
| Jun 30, 2025 | 87.31 Mn |
| Mar 31, 2025 | 115.49 Mn |
| Dec 31, 2024 | 97.18 Mn |
| Sep 30, 2024 | 92.43 Mn |
| Jun 30, 2024 | 94.51 Mn |
| Mar 31, 2024 | 213.46 Mn |
| Sep 30, 2023 | 316.74 Mn |
| Jun 30, 2023 | 316.25 Mn |
| Mar 31, 2023 | 315.76 Mn |
| Dec 31, 2022 | 315.29 Mn |
| Sep 30, 2022 | 314.82 Mn |
| Jun 30, 2022 | 314.36 Mn |
| Mar 31, 2022 | 313.90 Mn |
| Dec 31, 2021 | 313.46 Mn |
| Sep 30, 2021 | 313.02 Mn |
| Jun 30, 2021 | 312.59 Mn |
| Mar 31, 2021 | 312.16 Mn |